Advertisement

Topics

Platinum Equity's $2.1B offer for LifeScan accepted by J&J

07:05 EDT 13 Jun 2018 | SmartBrief

Johnson & Johnson has formally accepted a binding offer from Platinum Equity, valued at $2.1 billion, for its diabetes monito -More

Original Article: Platinum Equity's $2.1B offer for LifeScan accepted by J&J

NEXT ARTICLE

More From BioPortfolio on "Platinum Equity's $2.1B offer for LifeScan accepted by J&J"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...